The study was powered to investigate whether there was a difference from 45% to 60% in 2-year survival rates in patients with early-stage NSCLC treated with induction chemotherapy followed by surgery versus a control group of patients receiving primary surgery.
|Number of pages||1|
|Journal||Journal of Clinical Oncology|
|Publication status||Published - 15 May 2002|
- preoperative chemotherapy
- lung cancer
De Pas, T., Pastorino, U., Spaggiari, L., Curigliano, G., de Braud, F., & Robertson, C. (2002). Preoperative chemotherapy in non-small-cell lung cancer: nothing new in n2 disease. Journal of Clinical Oncology, 20(10), 2603-2604.